| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [X. W. W., M. K. G., H. Y., K. F., C. C. H.]; Department of Cell Biology and Genetics, Medical Genetics Center, Erasmus University Rotterdam, 3000 DR Rotterdam, the Netherlands [W. V., J. H. J. H.]; and Fur Experimentelle Virologie and Immunologie, Heinrich-Pette-Institut, An Der Universitat Hamburg, D-20251 Hamburg, Germany [H-W. S.]
The p53 tumor suppressor gene product is a transcriptional transactivator and a potent apoptotic inducer. The fact that many of the DNA tumor virus oncoproteins bind to p53 and affect these p53 functions indicates that this interaction is an important step in oncogenic transformation. We and others have recently demonstrated that the hepatitis B virus oncoprotein, HBx, can form a complex with p53 and inhibit its DNA consensus sequence binding and transcriptional transactivator activity. Using a microinjection technique, we report here that HBx efficiently blocks p53-mediated apoptosis and describe the results of studies exploring two possible mechanisms of HBx action. First, inhibition of apoptosis may be a consequence of the failure of p53, in the presence of HBx, to upregulate genes, such as p21WAF1, Bax, or Fas, that are involved in the apoptotic pathway. Data consistent with this hypothesis include HBx reduction of p53-mediated p21WAF1 expression. Alternatively, HBx could affect p53 binding to the TFIIH transcription-nucleotide excision repair complex as HBx binds to the COOH terminus of p53 and inhibits its binding to XPB or XPD. Binding of p53 to these constituents of the core TFIIH is a process that may be involved in apoptosis. Because the HBx gene is frequently integrated into the genome of hepatocellular carcinoma cells, inhibition of p53-mediated apoptosis by HBx may provide a clonal selective advantage for hepatocytes expressing this integrated viral gene during the early stages of human liver carcinogenesis.
1 W. V. and J. H. J. H. gratefully acknowledge financial support from the Dutch Cancer Society (project EUR 94763) and the Medica Sciences section of the Dutch Scientific Organization (project 501-93 and 151). M. G. and H. Y. were Howard Hughes Medical Institute-NIH Research Scholars.
2 To whom requests for reprints should be addressed, at Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Building 37, Room 2C01, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255.
Received 10/ 5/95. Accepted 11/ 1/95.
This article has been cited by other articles:
![]() |
W. Jiang, C. W. Bell, and D. S. Pisetsky The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid J. Immunol., May 15, 2007; 178(10): 6495 - 6503. [Abstract] [Full Text] [PDF] |
||||
![]() |
N H Park, I H Song, and Y-H Chung Chronic hepatitis B in hepatocarcinogenesis. Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. C. Lee, J. Ren, E.-T. Wong, K. H. K. Ban, L. A. Lee, and C. G. L. Lee The Hepatitis B Virus X Protein Sensitizes HepG2 Cells to UV Light-induced DNA Damage J. Biol. Chem., September 30, 2005; 280(39): 33525 - 33535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tokusumi, S. Zhou, and S. Takada Nuclear Respiratory Factor 1 Plays an Essential Role in Transcriptional Initiation from the Hepatitis B Virus X Gene Promoter J. Virol., October 15, 2004; 78(20): 10856 - 10864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kalra and V. Kumar c-Fos Is a Mediator of the c-Myc-induced Apoptotic Signaling in Serum-deprived Hepatoma Cells via the p38 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., June 11, 2004; 279(24): 25313 - 25319. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Feng, W. Hu, and M.-s. Tang Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: A possible mechanism for lipid peroxidation-induced carcinogenesis PNAS, June 8, 2004; 101(23): 8598 - 8602. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kwun and K. L. Jang Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene Nucleic Acids Res., April 23, 2004; 32(7): 2202 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chami, D. Ferrari, P. Nicotera, P. Paterlini-Brechot, and R. Rizzuto Caspase-dependent Alterations of Ca2+ Signaling in the Induction of Apoptosis by Hepatitis B Virus X Protein J. Biol. Chem., August 22, 2003; 278(34): 31745 - 31755. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Shih, M.-L. Kuo, S.-E. Chuang, A.-L. Cheng, and S.-L. Doong Hepatitis B Virus X Protein Activates a Survival Signaling by Linking Src to Phosphatidylinositol 3-Kinase J. Biol. Chem., August 22, 2003; 278(34): 31807 - 31813. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Forgues, M. J. Difilippantonio, S. P. Linke, T. Ried, K. Nagashima, J. Feden, K. Valerie, K. Fukasawa, and X. W. Wang Involvement of Crm1 in Hepatitis B Virus X Protein-Induced Aberrant Centriole Replication and Abnormal Mitotic Spindles Mol. Cell. Biol., August 1, 2003; 23(15): 5282 - 5292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou and C. Prives Replication of damaged DNA in vitro is blocked by p53 Nucleic Acids Res., July 15, 2003; 31(14): 3881 - 3892. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Makower, A. Rozenblit, H. Kaufman, M. Edelman, M. E. Lane, J. Zwiebel, H. Haynes, and S. Wadler Phase II Clinical Trial of Intralesional Administration of the Oncolytic Adenovirus ONYX-015 in Patients with Hepatobiliary Tumors with Correlative p53 Studies Clin. Cancer Res., February 1, 2003; 9(2): 693 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Chen, C.-F. Kao, C.-M. Chen, C.-M. Shih, M.-J. Hsu, C.-H. Chao, S.-H. Wang, L.-R. You, and Y.-H. W. Lee Mechanisms for Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatitis C Virus Core Protein J. Biol. Chem., January 3, 2003; 278(1): 591 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, Z. Feng, J. Eveleigh, G. Iyer, J. Pan, S. Amin, F.-L. Chung, and M.-s. Tang The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma Carcinogenesis, November 1, 2002; 23(11): 1781 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-I Yang, S.-N. Lu, Y.-F. Liaw, S.-L. You, C.-A. Sun, L.-Y. Wang, C. K. Hsiao, P.-J. Chen, D.-S. Chen, C.-J. Chen, et al. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma N. Engl. J. Med., July 18, 2002; 347(3): 168 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Majumder, A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner J. Virol., February 1, 2001; 75(3): 1401 - 1407. [Abstract] [Full Text] |
||||
![]() |
S.-F. Chang, H. J. Netter, E. Hildt, R. Schuster, S. Schaefer, Y.-C. Hsu, A. Rang, and H. Will Duck Hepatitis B Virus Expresses a Regulatory HBx-Like Protein from a Hidden Open Reading Frame J. Virol., January 1, 2001; 75(1): 161 - 170. [Abstract] [Full Text] |
||||
![]() |
F. Su, C. N. Theodosis, and R. J. Schneider Role of NF-{kappa}B and Myc Proteins in Apoptosis Induced by Hepatitis B Virus HBx Protein J. Virol., January 1, 2001; 75(1): 215 - 225. [Abstract] [Full Text] |
||||
![]() |
J. Pan, L.-X. Duan, B. S. Sun, and M. A. Feitelson Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-{{kappa}}B J. Gen. Virol., January 1, 2001; 82(1): 171 - 182. [Abstract] [Full Text] |
||||
![]() |
C. R. Madden, M. J. Finegold, and B. L. Slagle Expression of Hepatitis B Virus X Protein Does Not Alter the Accumulation of Spontaneous Mutations in Transgenic Mice J. Virol., June 1, 2000; 74(11): 5266 - 5272. [Abstract] [Full Text] |
||||
![]() |
D. Lepik and M. Ustav Cell-Specific Modulation of Papovavirus Replication by Tumor Suppressor Protein p53 J. Virol., May 15, 2000; 74(10): 4688 - 4697. [Abstract] [Full Text] |
||||
![]() |
D. J. Brick, R. D. Burke, A. A. Minkley, and C. Upton Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis J. Gen. Virol., April 1, 2000; 81(4): 1087 - 1097. [Abstract] [Full Text] |
||||
![]() |
Y. Shintani, H. Yotsuyanagi, K. Moriya, H. Fujie, T. Tsutsumi, Y. Kanegae, S. Kimura, I. Saito, and K. Koike Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system J. Gen. Virol., December 1, 1999; 80(12): 3257 - 3265. [Abstract] [Full Text] |
||||
![]() |
A. PERL Mechanisms of viral pathogenesis in rheumatic disease Ann Rheum Dis, August 1, 1999; 58(8): 454 - 461. [Full Text] |
||||
![]() |
T. Minamoto, M. Mai, and Z.'e. Ronai Environmental factors as regulators and effectors of multistep carcinogenesis Carcinogenesis, April 1, 1999; 20(4): 519 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Groisman, R. Koshy, F. Henkler, J. D. Groopman, and M. A. Alaoui-Jamali Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells Carcinogenesis, March 1, 1999; 20(3): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, X. W. Wang, L. Xu, K. Hagiwara, M. Nagashima, R. Wolkowicz, I. Zurer, V. Rotter, and C. C. Harris COOH-Terminal Domain of p53 Modulates p53-mediated Transcriptional Transactivation, Cell Growth, and Apoptosis Cancer Res., February 1, 1999; 59(4): 843 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prost, J. M. Ford, C. Taylor, J. Doig, and D. J. Harrison Hepatitis B x Protein Inhibits p53-dependent DNA Repair in Primary Mouse Hepatocytes J. Biol. Chem., December 11, 1998; 273(50): 33327 - 33332. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gottlob, M. Fulco, M. Levrero, and A. Graessmann The Hepatitis B Virus HBx Protein Inhibits Caspase 3 Activity J. Biol. Chem., December 11, 1998; 273(50): 33347 - 33353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perz and J. G. Kuhn Review : p53 in the pathogenesis, diagnosis, and treatment of cancer Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102. [Abstract] [PDF] |
||||
![]() |
T. Fan, H. Lu, H. Hu, L. Shi, G. A. McClarty, D. M. Nance, A. H. Greenberg, and G. Zhong Inhibition of Apoptosis in Chlamydia-infected Cells: Blockade of Mitochondrial Cytochrome c Release and Caspase Activation J. Exp. Med., February 16, 1998; 187(4): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, H. Lee, and Y. Yun X-gene Product of Hepatitis B Virus Induces Apoptosis in Liver Cells J. Biol. Chem., January 2, 1998; 273(1): 381 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Elmore, A. R. Hancock, S.-F. Chang, X. W. Wang, S. Chang, C. P. Callahan, D. A. Geller, H. Will, and C. C. Harris Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis PNAS, December 23, 1997; 94(26): 14707 - 14712. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Jones and G. J. Gores Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chirillo, S. Pagano, G. Natoli, P. L. Puri, V. L. Burgio, C. Balsano, and M. Levrero The hepatitis B virus X gene induces p53-mediated programmed cell death PNAS, July 22, 1997; 94(15): 8162 - 8167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yanagisawa, M. Takahashi, H. Kanki, H. Yano-Yanagisawa, T. Tazunoki, E. Sawa, T. Nishitoba, M. Kamishohara, E. Kobayashi, S. Kataoka, et al. The Molecular Interaction of Fas and FAP-1. A TRIPEPTIDE BLOCKER OF HUMAN Fas INTERACTION WITH FAP-1 PROMOTES Fas-INDUCED APOPTOSIS J. Biol. Chem., March 28, 1997; 272(13): 8539 - 8545. [Abstract] [Full Text] [PDF] |
||||
![]() |
X W Wang, W Vermeulen, J D Coursen, M Gibson, S E Lupold, K Forrester, G Xu, L Elmore, H Yeh, J H Hoeijmakers, et al. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes & Dev., May 15, 1996; 10(10): 1219 - 1232. [Abstract] [PDF] |
||||
![]() |
M. Otsuka, N. Kato, K.-H. Lan, H. Yoshida, J. Kato, T. Goto, Y. Shiratori, and M. Omata Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability J. Biol. Chem., October 27, 2000; 275(44): 34122 - 34130. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Shih, M.-L. Kuo, S.-E. Chuang, A.-L. Cheng, and S.-L. Doong Hepatitis B Virus X Protein Inhibits Transforming Growth Factor-beta -induced Apoptosis through the Activation of Phosphatidylinositol 3-Kinase Pathway J. Biol. Chem., August 11, 2000; 275(33): 25858 - 25864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Ogden, K. C. Lee, and M. C. Barton Hepatitis B Viral Transactivator HBx Alleviates p53-mediated Repression of alpha -Fetoprotein Gene Expression J. Biol. Chem., September 1, 2000; 275(36): 27806 - 27814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Diao, A. A. Khine, F. Sarangi, E. Hsu, C. Iorio, L. A. Tibbles, J. R. Woodgett, J. Penninger, and C. D. Richardson X Protein of Hepatitis B Virus Inhibits Fas-mediated Apoptosis and Is Associated with Up-regulation of the SAPK/JNK Pathway J. Biol. Chem., March 9, 2001; 276(11): 8328 - 8340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. I. Lee, S. Kang-Park, S.-I. Do, and Y. I. Lee The Hepatitis B Virus-X Protein Activates a Phosphatidylinositol 3-Kinase-dependent Survival Signaling Cascade J. Biol. Chem., May 11, 2001; 276(20): 16969 - 16977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Forgues, A. J. Marrogi, E. A. Spillare, C.-G. Wu, Q. Yang, M. Yoshida, and X. W. Wang Interaction of the Hepatitis B Virus X Protein with the Crm1-dependent Nuclear Export Pathway J. Biol. Chem., June 15, 2001; 276(25): 22797 - 22803. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |